PROSPECTIV-a Pilot Trial of a Nurse-led Psychoeducational Intervention Delivered in Primary Care to Prostate Cancer Survivors: Study Protocol for a Randomised Controlled Trial
Overview
Authors
Affiliations
Background: Prostate cancer survivors can experience physical, sexual, psychological and emotional problems, and there is evidence that current follow-up practices fail to meet these men's needs. Studies show that secondary and primary care physicians see a greater role for primary care in delivering follow-up, and that primary care-led follow-up is acceptable to men with prostate cancer.
Methods And Analysis: A two-phase study with target population being men who are 9-24 months from diagnosis. Phase 1 questionnaire aims to recruit 300 men and measure prostate-related quality of life and unmet needs. Men experiencing problems with urinary, bowel, sexual or hormonal function will be eligible for phase 2, a pilot trial of a primary care nurse-led psychoeducational intervention. Consenting eligible participants will be randomised either to intervention plus usual care, or usual care alone (40 men in each arm). The intervention, based on a self-management approach, underpinned by Bandura's Social Cognitive Theory, will provide advice and support tailored to these men's needs and address any problems they are experiencing. Telephone follow-up will take place at 6 months. Study outcomes will be measured by a questionnaire at 7 months. Phase 1 will allow us to estimate the prevalence of urinary, sexual, bowel and hormone-related problems in prostate cancer survivors and the level of unmet needs. 'Usual care' will also be documented. Phase 2 will provide information on recruitment and retention, acceptability of the intervention/outcome measures, effect sizes of the intervention and cost-effectiveness data, which is required to inform development of a larger, phase 3 randomised controlled trial. The main outcome of interest is change in prostate-cancer-related quality of life. Methodological issues will also be addressed.
Ethics And Dissemination: Ethics approval has been gained (Oxford REC A 12/SC/0500). Findings will be disseminated in peer-reviewed journals, at conferences, through user networks and relevant clinical groups.
Trial Registration Number: ISRCTN 97242511.
Cavers D, Cunningham-Burley S, Watson E, Banks E, Campbell C Health Expect. 2024; 27(5):e70039.
PMID: 39369340 PMC: 11456226. DOI: 10.1111/hex.70039.
Educational Needs in Oncology Nursing: A Scoping Review.
Solera-Gomez S, Benedito-Monleon A, LLinares-Insa L, Sancho-Cantus D, Navarro-Illana E Healthcare (Basel). 2022; 10(12).
PMID: 36554019 PMC: 9778242. DOI: 10.3390/healthcare10122494.
Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.
L Hoeg B, Bidstrup P, Karlsen R, Friberg A, Albieri V, Dalton S Cochrane Database Syst Rev. 2019; 2019(11).
PMID: 31750936 PMC: 6870787. DOI: 10.1002/14651858.CD012425.pub2.
Cavers D, Habets L, Cunningham-Burley S, Watson E, Banks E, Campbell C J Cancer Surviv. 2019; 13(1):148-159.
PMID: 30685822 PMC: 6394454. DOI: 10.1007/s11764-019-0734-z.
Frankland J, Brodie H, Cooke D, Foster C, Foster R, Gage H BMC Cancer. 2017; 17(1):656.
PMID: 28927389 PMC: 5606080. DOI: 10.1186/s12885-017-3643-4.